The Valley Desk

NCT03359473 · Interventional trial

Study to Evaluate the Safety and Efficacy of 13 Weeks of the Selective Androgen Receptor Modulator (SARM) GSK2881078 in Chronic Obstructive Pulmonary Disease (COPD)

Overall registry status Completed

Phase 2

Conditions Cachexia

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov